Crinetics Pharmaceuticals to Present Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs at ENDO 2024 Initial Data from Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia to be Presented, Along with Initial Findings from Phase 1b/2a ACTH-Dependent Cushing’s Syndrome Trial Data from Phase 3 PATHFNDR 1 and 2 Trials of Paltusotine in Acromegaly will be Presented, in Addition to New Long-Term Safety and Efficacy Findings SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced five abstracts from its clinical development programs, inclu...
Allot Announces the Appointment of Eyal Harari as Chief Executive Officer Hod Hasharon, Israel, May 06, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: ALLT, TASE: ALLT), a leading global provider of innovative network intelligence and security solutions for service providers and enterprises worldwide, today announced the appointment of Eyal Harari as its Chief Executive Officer effective May 6, 2024. He will be replacing Mr. Erez Antebi. At the request of the company's Board of Directors, Mr. Antebi has agreed to assist Mr. Harari during a transition period and thereafter, to continue to provide co...
Trupanion Reports First Quarter 2024 Results SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, today announced financial results for the first quarter ended March 31, 2024. “It was a solid start to the year, with performance across our key financial metrics as expected,” said Margi Tooth, President of Trupanion. “Subscription revenue increased by 22% year-over-year. Moreover, discretionary profit from our core subscription business increased 55% while acquisition spend decreased 23% year-over-year. We co...
Sprout Social Announces First Quarter 2024 Financial Results Expects durable, efficient growth in 2024 CHICAGO, May 02, 2024 (GLOBE NEWSWIRE) -- Sprout Social, Inc. (“Sprout Social”, the “Company”) (Nasdaq: SPT), an industry-leading provider of cloud-based social media management software, today announced financial results for its first quarter ended March 31, 2024. “As partners in this company’s success to date and strategic direction moving forward, Ryan and I had an opportunity to re-draw our roles to best position us to accelerate beyond our $1B target.” said Justyn How...
Crinetics Pharmaceuticals to Report First Quarter 2024 Financial Results on May 9, 2024 SAN DIEGO, May 02, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CRNX) today announced that it will report first quarter 2024 financial results on Thursday, May 9, 2024, after the close of the U.S. financial markets. Company management will host a conference call at 4:30 p.m. ET to discuss financial results and provide a business update. Conference Call & Webcast Thursday, May 9th @ 4:30 PM ETDomestic:1-888-886-7786International:1-416-764-8658Conference ID: 71864759 Participants can use Guest dial-in #s above ...
Trupanion’s Margi Tooth Appointed Chief Executive Officer Effective August 1, 2024 Founder and CEO Darryl Rawlings to continue to serve as Chair of the Board in furtherance of previously announced succession plan SEATTLE, May 02, 2024 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced that its Board of Directors has unanimously approved the appointment of Margi Tooth to Chief Executive Officer, effective August 1, 2024. Tooth’s appointment to CEO marks the culmination of a multi-year, board-led process. Tooth will also c...
Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 Webcast and Conference Call To be Held Thursday, May 9th, 2024, 8:30 am ET NEW YORK, May 02, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome, schizophrenia and other central nervous system (CNS) diseases, today announced...
TROY, Mich.--(BUSINESS WIRE)-- Skyline Champion Corporation (NYSE: SKY) ("Skyline Champion"), will release its earnings results for the fourth quarter and full year 2024 after the market closes on Tuesday, May 21, 2024. Skyline Champion will hold a conference call to discuss the results the following morning, Wednesday, May 22, 2024, at 9:00 A.M. Eastern Time. Interested investors and other parties can listen to a webcast of the live conference call by logging onto the Investor Relations section of Skyline Champion’s website at . The online replay will be available on the same website immedi...
Progyny, Inc. Announces Details for Its First Quarter 2024 Results Report NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended March 31, 2024 after the close of the market on Thursday, May 9, 2024. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States...
New Research Reveals Influencers Significantly Drive Purchasing Decisions In addition to a rising trust in influencers, the new report from Sprout Social shows nearly half of consumers make a purchase at least once a month because of influencers CHICAGO, April 25, 2024 (GLOBE NEWSWIRE) -- Influencers have cemented themselves as key components of modern marketing strategies, and new research reveals the significant power they have in directly shaping consumer purchasing behaviors. According to released today by an industry-leading provider of cloud-based social media management softwar...
AMMO, Inc. Announces Acquisition of Tooling Manufacturer Insourcing of tool manufacturing expected to achieve over$1 million in annualized cost savings SCOTTSDALE, Ariz., April 25, 2024 (GLOBE NEWSWIRE) -- AMMO, Inc. (Nasdaq: POWW, POWWP) (“AMMO” or the “Company”) the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announces that it has acquired a tooling manufacturer that provides key resources toward the production of ammunition...
Trupanion, Inc. Announces First Quarter 2024 Earnings Release and Conference Call SEATTLE, April 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 first quarter after the market closes on Thursday, May 2, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET. A live webcast, to include a slide presentation, will be available on Trupanion's Investor Relations site under Investor Events at and will be archived onli...
A director at Hubspot Inc sold after exercising options/sold 8,500 shares at 636.180USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...
Progyny and Fertility Matters Canada Recognize Canadian Fertility Awareness Week to Advocate for Expanded Access to Family Building Care The organizations will host an event with Canada’s leading providers, employers, and fertility advocates to show support for the millions in need of family building care NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, and , a national fertility patient-focused organization, today announced both organizations will be co-hosting an event to garner support for...
Trupanion Publishes 2023 Annual Letter to Shareholders SEATTLE, April 16, 2024 (GLOBE NEWSWIRE) -- , Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has published its 2023 annual shareholder letter, co-written by CEO and Chair, Darryl Rawlings, and President, Margi Tooth. The letter is now available on the Company’s Investor Relations website . About Trupanion Trupanion is a leader in medical insurance for cats and dogs throughout the United States, Canada, Europe, Puerto Rico and Australia with over 1,000,000 pets enrolled. For over two decades, Trup...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.